Brief: Galectin Therapeutics Announces $20 Million Convertible Debt Financing From Its Chairman, Richard E. Uihlein
21/09/2021 13:49
Sept 21 (Reuters) - Galectin Therapeutics Inc GALT.O :
* GALECTIN THERAPEUTICS ANNOUNCES $20 MILLION CONVERTIBLE
DEBT
FINANCING FROM ITS CHAIRMAN, RICHARD E. UIHLEIN
Source text for Eikon: ID:nGNX53GDFd
Further company coverage: GALT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Galectin Therapeutics
See all newsGalectin Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Galectin Therapeutics Reports June 30, 2026 Financial Results
Galectin Therapeutics Q2 loss widens
Galectin Therapeutics Inc expected to post a loss of 9 cents a share - Earnings Preview
Galectin Therapeutics rises as FDA clears path for late-stage liver drug study